EC 3.4.99.26;UROKINASE UPA 2-CHAIN;UROKINASE;UROKINASE 2-CHAIN;UROKINASE, HIGH MOLECULAR WEIGHT;UROKINASE, HIGH MW (URINE);win-kinase;Kinase (enzyme-activating), uro-
MDL No.
-
用途
Urokinase is used as a potent thrombolytic agent for the treatment of acute myocardial infarction, unstable angina, cerebrovascular diseases, arterial thromboembolic diseases, thrombotic thrombocytopenic purpura, and systemic lupus erythematosus; it is also used in cancer therapy. It is effective in treating cerebral embolism, deep vein thrombosis, peripheral arterial and venous thrombosis, pulmonary embolism, myocardial infarction, and retiform thrombotic disorders. Urokinase is a specific protease that cleaves plasminogen to form plasmin, and it binds to the urokinase plasminogen activator receptor (uPAR), thereby regulating cell adhesion, tissue remodeling, cell migration, and activating intracellular signaling pathways.